CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 4 Planned sale See remarks sold 80,909 shares at an average $4.27 ($345,572)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Legal Officer sold 299 shares at $4.38 ($1,310)
- 4 Open-market sale President, R&D sold 657 shares at $4.38 ($2,878)
- 4 Planned sale Chief Financial Officer sold 4,865 shares at an average $4.42 ($21,491)
- 4 Open-market sale See remarks sold 400 shares at $4.38 ($1,752)
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 100,000 shares at $5.00 ($500,000)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 9 of 28 · 556 filings